Dynamic inositol pyrophosphate synthesis is a targetable therapeutic opportunity in ovarian cancer.
Daniel P. Bondeson, David Husselbee, Saoirse Hanbury, Amirshayan Chadeganipour, Gabriel Mesa, Alison Cameron, Janhavi Y. Sawant, Carly R. Langan, Tuhina Bhattacharya, YuhJong Liu, Hajer Siala, Erin M Swanson, Mustafa Kocak, Karthik Srinivasan, Blanche C. Ip, , Todd R. Golub
This study evaluates strategies to inhibit XPR1 in ovarian cancer, showing that IP6K inhibitors effectively mimic XPR1 inhibition by blocking phosphate efflux and reducing tumor burden in xenograft models.
bioRxiv · Aug 26, 2026 · PreprintCancer Biology